Rocket Lab shares fell 8.5% during Friday’s session, swinging to their lowest intraday level since May before recovering slightly by the close. Trading volume reached roughly 22.8 million shares—8% above the three-month daily average—indicating heightened selling pressure. The sharp pullback follows a recent peak and comes as investors reassess growth expectations for the small-satellite launch specialist.

Among 15 analysts covering the company, two rate it a strong buy, seven a buy, five a hold and one a sell, resulting in a consensus of Moderate Buy. Price targets range widely, with the most bullish projecting gains exceeding 30% from current levels and the most conservative forecasting a flat outlook. Recent revisions include Morgan Stanley lowering its target and Citigroup reaffirming its market-perform view, while KeyCorp and Needham have each raised theirs on improving launch cadence and margin trends.

In its latest quarterly report, Rocket Lab posted revenue of $155 million, up 48% year-over-year and exceeding consensus by nearly $3 million. Adjusted loss per share of three cents topped estimates by two cents, driven by stronger Electron launch activity and higher spacecraft sales. Despite a 36% net loss margin, the company’s order backlog expanded, and management forecasted full-year revenue growth approaching 45%, supported by a growing manifest of government and commercial missions.

Senior executives have reduced holdings modestly, selling approximately 15,000 shares each in late November at an average price in the low-forties, representing less than 3% of individual insider stakes. Over the past 90 days, insider sales total about 2.7 million shares. Meanwhile, institutional ownership remains high at 72%, with Russell Investments, Raymond James and Vident Advisory collectively adding over 600,000 shares during recent quarters, reflecting divergent views on near-term capital needs versus long-term growth potential.